AzTrials
AzTrials

Memory DisordersNCT05999071

Coriandrum Sativum Seeds Improve Memory, Alleviate Anxiety and Depression, and Enhance Sleep Quality in University Students: A Randomized Controlled Trial

A study testing Coriandrum sativum seeds in people with Memory Disorders and Anxiety Depression, run by The Hashemite University at 1 site in Jordan.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

C. sativum could potentially serve as a memory enhancer for university students. It is considered a preferable option to stimulant drugs due to its safety profile. Additionally, C. sativum may have positive effects on anxiety, depression, and sleep quality. Read more about this study

Who is it for?
Ages 19 to 23 yearsHealthy volunteers can take part
Conditions the study is for
Memory Disorders, Anxiety Depression, Sleep
What is being tested?
Coriandrum sativum seeds
Type of treatment
Pill or oral medicine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
86 participants
Where
1 siteJordan
Study dates
1 Mar 2022to 1 Jul 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 19 to 23 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male or female university Student.
  • 19-23 of age

Who cannot join

  • Medical diseases.
  • Psychiatric disorders.
  • Using any form of medication (including complementary and alternative medicines).
  • Pregnant and lactating individuals.

Trial locations and contacts

1 site in 1 country.

Jordan1 site
  • Faculty of Pharmaceutical Sciences

    Zarqa, 13133

Other trials in Jordan

About this study

  1. sativum could potentially serve as a memory enhancer for university students. It is considered a preferable option to stimulant drugs due to its safety profile. Additionally, C. sativum may have positive effects on anxiety, depression, and sleep quality. However, it is important to note that the current body of research on the effects of oral C. sativum on the brain and nervous system is limited, and further studies are necessary to fully understand its potential benefits. Thus, this study aims to assess the impact of oral C. sativum on memory performance, anxiety, depression, and sleep quality in university students.
Read the detailed description

Coriander, scientifically known as Coriandrum sativum L (C. sativum), is an ancient herb that belongs to the Apiaceae family. It has a rich history of more than 3,000 years of use in both culinary and medicinal practices. While originally native to Mediterranean regions, coriander is now cultivated in various countries worldwide. In traditional medicine, all parts of the coriander plant have been consumed and utilized to address gastrointestinal ailments like anorexia, dyspepsia, flatulence, diarrhea, pain, and vomiting. In Jordanian traditional medicine, C. sativum has been valued for its anticonvulsant, antidepressant, sedative, and anxiolytic properties. Studies have reported diverse health benefits associated with C. sativum seeds and leaves, including antioxidant, diuretic, cholesterol-lowering, anxiolytic, sedative-hypnotic, and anticonvulsant activities. Notably, the main component of C. sativum, linalool, along with γ-terpinene and α-pinene, exhibit various neuropharmacological effects, such as anti-anxiety, sedative, anticonvulsant, and anti-Alzheimer's disease properties. Additionally, C. sativum seeds are recognized as a valuable source of vitamins, lipids, and minerals like potassium, calcium, phosphorus, magnesium, sodium, and zinc.

Several studies have indicated the positive effects of C. sativum on memory, anxiety, and depression. In a specific study, the aqueous extract derived from the seeds of C. sativum demonstrated significant reductions in monoamine oxidase-B (MAO-B) activity over time, suggesting its primary role in exerting antidepressant-like effects. Another study reported that the administration of C. sativum leaves improved memory performance and hindered the aging process in rats in a dose-dependent manner. Furthermore, it was observed that C. sativum leaves reversed memory impairments induced by scopolamine and diazepam, while also significantly reducing brain cholinesterase activity and serum total cholesterol levels. Another study evaluated the effects of the ethanolic extract of C. sativum seeds on learning in second-generation mice. Although the plant extract did not enhance learning in the short term following training, it did show improvements in long-term learning. Additionally, in an animal model of anxiety, the effects of different doses (10 mg/kg, 25 mg/kg, 50 mg/kg, and 100 mg/kg administered intraperitoneally) of the aqueous extract of C. sativum seeds were evaluated in terms of motor activity and neuromuscular function. In the elevated plus-maze test, the 100 mg/kg dose of the seeds' aqueous extract exhibited anxiolytic effects by increasing the time spent in and the number of entries into the open arms.

Anxiety, depression, and sleep disorders are prevalent among university students, and these conditions can have a considerable impact on their memory function. Consequently, there has been a rise in the use of stimulant drugs among university students as a means to enhance memory performance and attention, despite the fact that such use is unapproved and non-therapeutic which might be associated with several side effects. As a result, there is a growing interest among neuroscience researchers to identify cognitive-enhancing drugs that can be safely used by healthy individuals without adverse effects.

Given the information provided, it is suggested that C. sativum could potentially serve as a memory enhancer for university students. It is considered a preferable option to stimulant drugs due to its safety profile. Additionally, C. sativum may have positive effects on anxiety, depression, and sleep quality. However, it is important to note that the current body of research on the effects of oral C. sativum on the brain and nervous system is limited, and further studies are necessary to fully understand its potential benefits. Thus, this study aims to assess the impact of oral C. sativum on memory performance, anxiety, depression, and sleep quality in university students.

Being tested
Coriandrum sativum seeds
Keywords
Coriandrum sativum, memory performance, anxiety, depression, sleep
Medical subject headings
Memory Disorders, Anxiety Disorders, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Coriandrum sativum seedsDietary supplement

    Also called Coriandrum

    Each group consisted of 50 students. In the C. sativum group, dried powdered seeds of C. sativum were administered, while in the control group, starch was provided as a placebo. Both the C. sativum and placebo capsules were identical in shape, color, and outer packaging to maintain the blinding of the participants.

Study groups in NCT05999071
Study groupRoleWhat they receive
Coriandrum sativum groupExperimental500 mg of C. sativum (capsules) were administered twice daily
Receives: Dietary Supplement: Coriandrum sativum seeds
control groupPlacebo comparator500 mg of starch (capsules) were administered twice daily
Receives: Dietary Supplement: Coriandrum sativum seeds

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Memory performance

    Prospective and Retrospective Memory Questionnaire was performed

    Measured: 30 days

Secondary outcomes (2)
  1. Anxiety and depression

    Hospital Anxiety and Depression Scale was perfomed

    Measured: 30 days

  2. Sleep quality

    Pittsburgh Sleep Quality Inventory questionnaire was perfoemed

    Measured: 30 days

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Aug 2023
  2. Study start1 Mar 2022
  3. Primary completion1 Jul 2022
  4. Study completion1 Jul 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Triple blind
Who is masked
Participant, Care provider, Investigator
Enrolment
86 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05999071
Sponsor's protocol ID
21/6/2022/2023
Status last verified
Aug 2023
First submitted
3 Aug 2023
Last updated
21 Aug 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: All participants data will be hidden

Questions about this trial

What is this clinical trial studying?

A study testing Coriandrum sativum seeds in people with Memory Disorders and Anxiety Depression, run by The Hashemite University at 1 site in Jordan.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 21 Aug 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Jordan. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Memory performance (time frame: 30 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 21 Aug 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in